Absci Investor Presentation Deck

ABSCI IS THE LEADER IN GENERATIVE AI DRUG CREATION FOR BIOLOGICS Cycles completed within weeks Absci's rapid cycle times allow for: ABSCI CORPORATION 2023 ALL RIGHTS RESERVED DATA TO TRAIN Typical 6-week per cycle WET LAB TO VALIDATE 01 Rapid iteration and improvement of Al models 02 Reduction of preclinical development timelines and increased probability of success 03 AI TO CREATE Accelerated achievement of mission and attraction of top Al talent absci. 9

View entire presentation